The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).
 
Bjorn H. Henning Gronberg
Employment - Lilly O. (I)
Stock and Other Ownership Interests - Lilly O. (I)
Honoraria - AstraZeneca; BMS Norway; Debiopharm Group; Janssen; Lilly O.; MSD; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - AstraZeneca; Janssen; Lilly O.; MSD
Research Funding - AstraZeneca (Inst); Roche
 
Kristin Toftaker Killingberg
Honoraria - MSD/Merck
 
Øystein Fløtten
No Relationships to Disclose
 
Maria Moksnes Bjaanæs
Speakers' Bureau - Bristol-Myers Squibb/Roche
 
Tesfaye Madebo
No Relationships to Disclose
 
Tine Schytte
No Relationships to Disclose
 
Seppo Wang Langer
Employment - Genmab (I)
Leadership - Genmab (I)
Stock and Other Ownership Interests - Genmab (I)
Honoraria - MSD; Roche
Travel, Accommodations, Expenses - Janssen; MSD
 
Signe Leonora Risumlund
No Relationships to Disclose
 
Nina Helbekkmo
No Relationships to Disclose
 
Kirill Neumann
No Relationships to Disclose
 
Odd Terje Brustugun
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Sanofi/Regeneron
Consulting or Advisory Role - Bayer Health (Inst); MSD Oncology (Inst); Roche (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Øyvind Yksnøy
No Relationships to Disclose
 
Georgios Tsakonas
Honoraria - Roche
Consulting or Advisory Role - Atheneum; MSD; Roche
 
Jens Engleson
Honoraria - AstraZeneca; Roche
Consulting or Advisory Role - AstraZeneca; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Sverre Fluge
No Relationships to Disclose
 
Thor Naustdal
No Relationships to Disclose
 
Liv Ellen Giske
No Relationships to Disclose
 
Jan Nyman
No Relationships to Disclose
 
Tarje Onsøien Halvorsen
Honoraria - AstraZeneca; MSD; MSD; MSD; Pfizer; Pfizer; Pfizer; Pierre Fabre; Takeda
Consulting or Advisory Role - Sanofi
Research Funding - AstraZeneca (Inst); MSD (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD